J&J gets piggyBac from Transposagen to develop T-Cell therapies

By Dan Stanton+ Dan Stanton 26-Nov-2014 2014-11-26T00:00:00Z

Last updated on 26-Nov-2014 at 16:57 GMT 2014-11-26T16:57:43Z

There is an upsurge in biopharma request for cell and gene therapy applications, says Transposagen as it inks a deal with Janssen to develop allogeneic Chimeric Antigen Receptor (CAR) T-cells. Continue reading J – J gets piggyBac from Transposagen to develop T-Cell therapies